Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Leukemia, Lymphocytic, Chronic, B-Cell

cetylpyridinium chloride anhydrous has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhagat, G; Furman, RR; Gardner, JR; Gonen, M; Gueorguiev, VD; Heaney, ML; Manova, K; O'Connor, OA; Paoluzzi, L; Scotto, L1
Blonski, JZ; Gora-Tybor, J; Jamroziak, K; Jesionek-Kupnicka, D; Krawczynska, A; Lech-Maranda, E; Robak, T; Szmigielska-Kaplon, A; Wierzbowska, A1
Benet, I; Calvete, JJ; Dopazo, J; Farrás, R; García-Conde, J; Jantus Lewintre, E; José Terol, M; Marín, M; Montaner, D; Reinoso Martín, C1
Bilban, M; Chott, A; Demirtas, D; Döhner, H; Fonatsch, C; Gaiger, A; Heintel, D; Heller, G; Jäger, U; Kainz, B; Kienle, D; Kröber, A; Krömer-Holzinger, E; Le, T; Schwarzinger, I; Shehata, M; Stilgenbauer, S; Wagner, O; Zielinski, C; Zöchbauer-Müller, S1

Other Studies

4 other study(ies) available for cetylpyridinium chloride anhydrous and Leukemia, Lymphocytic, Chronic, B-Cell

ArticleYear
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.
    Blood, 2008, Oct-01, Volume: 112, Issue:7

    Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Boronic Acids; Bortezomib; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Health; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Membrane Potential, Mitochondrial; Mice; Microscopy, Confocal; Molecular Mimicry; Nitrophenols; Piperazines; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Sulfonamides; Tissue Donors; Xenograft Model Antitumor Assays

2008
Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow; Cell Movement; Endothelial Cells; Female; Health; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Prognosis

2009
Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; B-Lymphocytes; DNA-Binding Proteins; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Health; Humans; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Proto-Oncogene Proteins c-bcl-6

2009
Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.
    International journal of cancer, 2007, Nov-01, Volume: 121, Issue:9

    Topics: Alleles; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Line, Tumor; Chromosomes, Human, Pair 7; DNA Methylation; DNA-Binding Proteins; Down-Regulation; Gene Expression Regulation, Neoplastic; Genomic Imprinting; Health; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Nuclear Proteins; Polysaccharides; Proteins; Risk Factors; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering; Survival Rate; Ubiquitin-Protein Ligases

2007